Our previous study showed oxaliplatin‐resistant tumors had increased accumulation of PMN‐MDSCs and decreased CD8+ T cells, while there was no significant difference in the frequency of tumor‐associated macrophages (TAMs).17 The gene discussed is CD8A; the disease is neoplasm.